Recently, IRAK2 has also been described as a potential tumor suppressor in colon cancer that counterbalances oncogenic Smurf1 by phosphorylation of its threonine residues and promoting its self-degradation by ubiquitylation [107]. The gene discussed is SMURF1; the disease is malignant colon neoplasm.